4 October 2007
New Corporate Structure
Results of Court Meeting, EGM and Preference Shareholder Class Meeting
Reckitt Benckiser plc (the "Company") announces that at the meeting convened by
the Court and held earlier today (the "Court Meeting") and at the subsequent
Extraordinary General Meeting (the "EGM") to approve the scheme of arrangement
and other related matters whereby shares in the Company will be swapped for an
equivalent number of shares in Reckitt Benckiser Group plc, a new holding
company, all resolutions received the necessary majorities and were accordingly
approved. Shareholders at the EGM also approved resolutions to cancel the
Company's share premium account and capital redemption reserve and approved the
operation of new share schemes by Reckitt Benckiser Group plc, the principal
terms of which are summarised in the circular to shareholders dated 11
September 2007 (the "Circular").
Shareholders at the EGM and at the subsequent separate class meeting of the
Company's preference shareholders (the "Preference Shareholder Class Meeting")
also approved resolutions implementing the cancellation and repayment of the
Company's preference shares.
The full results of the meetings are available on the Company's website at
www.reckittbenckiser.com/downloads/pollstatements.pdf
Expected Timetable of Key Events
Last day for dealings in Reckitt Benckiser Ordinary 22 October 2007
Shares and Reckitt Benckiser Preference Shares
Scheme Record Time 6 p.m. 22 October
2007
Reckitt Benckiser Group plc ordinary shares listed on the 23 October 2007
London Stock Exchange and dealings commence
Court Hearing of petition to confirm reduction of capital 24 October 2007
of Reckitt Benckiser Group plc
Reckitt Benckiser Group plc reduction of capital 25 October 2007
effective
Despatch of payments for cancelled Uncertificated 26 October 2007
preference shares via CREST
Despatch of payments for cancelled Certificated 30 October 2007
preference shares via cheque
This timetable is based on the Board's expectations and may be subject to
change.
Financial Advice
The Board has received advice in relation to the Proposals from Credit Suisse
Securities (Europe) Limited.
Documents Available for Inspection
Copies of the resolutions passed at the Court Meeting, EGM and Preference
Shareholder Class Meeting will be submitted to the UKLA and will shortly be
available for viewing at the UKLA's Document Viewing Facility which is situated
at the following address: Financial Services Authority, 25 The North Colonnade,
Canary Wharf, London E14 5HS.
For Further Information
Reckitt Benckiser plc +44 (0) 1753 217800
Tom Corran SVP Investor Relations & Corporate Communications All Queries
Mark Wilson Corporate Controller & Investor Relations Manager Investor Queries
Fiona Fong Head of Corporate Communications Press Queries
Credit Suisse Securities (Europe) Limited +44 (0) 20 7888 8888
Piers de Montfort / Chris Byrne Investor Queries
Brunswick PR Agency +44 (0) 207 404 5959
Susan Gilchrist / Catherine Hicks Press Queries
Credit Suisse Securities (Europe) Limited is acting exclusively for the Company
and Reckitt Benckiser Group plc and no-one else in connection with the
Proposals and will not be responsible to anyone other than Reckitt Benckiser
and Reckitt Benckiser Group plc for providing the protections afforded to
clients of Credit Suisse Securities (Europe) Limited or for providing advice in
relation to the Proposals.
Terms used but not defined herein have the meanings given to them in the
Circular.
THIS DOCUMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN
OFFER TO BUY ANY SECURITY. NONE OF THE SECURITIES REFERRED TO IN THIS DOCUMENT
SHALL BE SOLD, ISSUED OR TRANSFERRED IN OR INTO ANY JURISDICTION IN
CONTRAVENTION OF APPLICABLE LAW.
Notice to United States residents
In particular, this document is not an offer of securities in the United
States. The Reckitt Benckiser Group Ordinary Shares will not be, and are not
required to be, registered with the US Securities and Exchange Commission (the
"SEC") under the US Securities Act of 1933, as amended (the "US Securities
Act"), or under the securities laws of any state, district or other
jurisdiction of the United States. It is expected that the Reckitt Benckiser
Group Ordinary Shares will be issued in reliance on the exemption from
registration provided by Section 3(a)(10) thereof. Reckitt Benckiser
Shareholders (whether or not US persons) who are affiliates (within the meaning
of the US Securities Act) of Reckitt Benckiser or Reckitt Benckiser Group
before implementation of the Scheme or who are affiliates of Reckitt Benckiser
Group after the implementation of the Scheme will be subject to timing, manner
of sale and volume restrictions on the sale of Reckitt Benckiser Group Ordinary
Shares received in connection with the Scheme under Rule 145(d) of the US
Securities Act.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.